Maria Hassan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Hassan has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Amir Zaib Abbasi
King Fahd University of Petroleum and Minerals Center for Finance and Digital Economy Dhahran
1 shared publication - Anum Sultan
Ziauddin University Hospital, Karachi-Pakistan
1 shared publication Daria M. Tanska
Authors' Affiliations: Departments of 1Radiation Oncology, 2Pharmacology, and 3Surgery, University of Michigan Medical School; 4Biostatistics Unit, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; and 5AstraZeneca R&D Boston, Waltham, Massachusetts
1 shared publicationDeborah Morosini
Authors' Affiliations: Departments of 1Radiation Oncology, 2Pharmacology, and 3Surgery, University of Michigan Medical School; 4Biostatistics Unit, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; and 5AstraZeneca R&D Boston, Waltham, Massachusetts
1 shared publication- Diane M. Simeone
Moores Cancer Center, UC San Diego Health, San Diego, USA
1 shared publication - Ding Hooi Ting
Universiti Teknologi PETRONAS
1 shared publication
Latest Publications
- 26 December 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Engineering Management
- Vol. 71 (00189391) , 3613-3628
Exploring the Impact of Gamified Experiences on User Engagement in Fitness Apps: A GAMEFULQUEST Perspective
Integrating game elements into gaming-related applications has long been recognized as a powerful tool for enhancing user engagement and overall effectiveness. Despite the numerous studies examining the impact of gamification on engagement, the specific factors that drive this phenomenon remain unclear. To address this knowledge gap, the present study employs the GAMEFULQUEST perspective in the context of fitness apps, exploring the effects of seven key gamified experience factors on consumer engagement. The study surveyed a sample of 240 users of various fitness gamified apps, operationalizing engagement through cognitive, affective, and behavioral dimensions. The results revealed that users' experiences of challenge, immersion, and social interaction significantly enhanced engagement, while accomplishments, competition, and guidance did not have a significant impact. Using GAMEFULQUEST, the model effectively explains and predicts consumer engagement, offering valuable insights both in theory and in practical application. This paper is a key contribution that leverages the GAMEFULQUEST approach to clearly explain the relationship between gamified experiences and user engagement with fitness apps, providing valuable insights for game designers and researchers alike.
- 26 December 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Engineering Management
- Vol. 71 (00189391) , 3613-3628
Exploring the Impact of Gamified Experiences on User Engagement in Fitness Apps: A GAMEFULQUEST Perspective
Integrating game elements into gaming-related applications has long been recognized as a powerful tool for enhancing user engagement and overall effectiveness. Despite the numerous studies examining the impact of gamification on engagement, the specific factors that drive this phenomenon remain unclear. To address this knowledge gap, the present study employs the GAMEFULQUEST perspective in the context of fitness apps, exploring the effects of seven key gamified experience factors on consumer engagement. The study surveyed a sample of 240 users of various fitness gamified apps, operationalizing engagement through cognitive, affective, and behavioral dimensions. The results revealed that users' experiences of challenge, immersion, and social interaction significantly enhanced engagement, while accomplishments, competition, and guidance did not have a significant impact. Using GAMEFULQUEST, the model effectively explains and predicts consumer engagement, offering valuable insights both in theory and in practical application. This paper is a key contribution that leverages the GAMEFULQUEST approach to clearly explain the relationship between gamified experiences and user engagement with fitness apps, providing valuable insights for game designers and researchers alike.
- Open Access
- 31 August 2020
- Published by Springer Nature in Cureus
- Vol. 12 (8)
Right Scapular Swelling Revealed to Be a Spontaneous Lateral Chest Wall Hematoma: An Intriguing Case Report
Chest wall hematoma commonly occurs as a result of blunt thoracic trauma. We report an intriguing case of spontaneous lateral chest wall hematoma that presented with right scapular swelling and tenderness on palpation having hemodynamic instability without any prior history of recent trauma or surgery. Chest x-ray and ultrasound were carried out at the time of admission to evaluate the swelling, followed by contrast-enhanced CT (CECT) of the chest to identify and localize the bleeder. Transcatheter arterial embolization (TAE) of the intercostal artery was performed to treat the condition successfully. CECT is found to be vitally important in localizing bleeders. Other possible options include exploratory thoracotomy, video-assisted thoracic surgery (VATS) exploration, and angiography.
- 31 August 2020
- Published by Springer Nature in Cureus
- Vol. 12 (8)
Open AccessRight Scapular Swelling Revealed to Be a Spontaneous Lateral Chest Wall Hematoma: An Intriguing Case Report
Chest wall hematoma commonly occurs as a result of blunt thoracic trauma. We report an intriguing case of spontaneous lateral chest wall hematoma that presented with right scapular swelling and tenderness on palpation having hemodynamic instability without any prior history of recent trauma or surgery. Chest x-ray and ultrasound were carried out at the time of admission to evaluate the swelling, followed by contrast-enhanced CT (CECT) of the chest to identify and localize the bleeder. Transcatheter arterial embolization (TAE) of the intercostal artery was performed to treat the condition successfully. CECT is found to be vitally important in localizing bleeders. Other possible options include exploratory thoracotomy, video-assisted thoracic surgery (VATS) exploration, and angiography.
- Open Access
- 16 May 2019
- Published by Springer Nature in Cureus
- Vol. 11 (5) , e4677
Diagnostic Accuracy of Echo-planar Diffusion-weighted Imaging in the Diagnosis of Intra-cerebral Abscess by Taking Histopathological Findings as the Gold Standard
To determine the diagnostic accuracy of echo-planar diffusion-weighted imaging (DWI) in the diagnosis of intra-cerebral abscesses by taking histopathological findings as the gold standard. A retrospective cross-sectional study was performed from July 2014 to June 2015 at a tertiary care hospital in Karachi. A total of 462 patients, who were referred for magnetic resonance imaging (MRI) brain, presenting with clinical suspicion of an intra-cerebral abscess on the basis of clinical signs and symptoms, were included in this study. MR imaging was performed. All patients subsequently underwent surgery. The histopathological findings of these patients were collected and compared with echo-planar diffusion-weighted MRI findings. A proforma was used to record the findings. The mean age of the patients was 47.39±13.54 years. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of echo-planar diffusion-weighted MRI in the diagnosis of intra-cerebral abscesses was 85.64%, 95.88%, 93.82%, 90.14%, and 91.56%, respectively. Brain abscesses and necrotic tumors are, most of the time, difficult to differentiate on routine conventional imaging, and prompt diagnosis is important, as an untreated brain abscess could be lethal. Diffusion imaging can aid in the diagnosis and further management plan so as to help in improved patient care. Although this sequence has high sensitivity and specificity, it should be used in addition to conventional imaging and not as a replacement of histopathology.
- 16 May 2019
- Published by Springer Nature in Cureus
- Vol. 11 (5) , e4677
Open AccessDiagnostic Accuracy of Echo-planar Diffusion-weighted Imaging in the Diagnosis of Intra-cerebral Abscess by Taking Histopathological Findings as the Gold Standard
To determine the diagnostic accuracy of echo-planar diffusion-weighted imaging (DWI) in the diagnosis of intra-cerebral abscesses by taking histopathological findings as the gold standard. A retrospective cross-sectional study was performed from July 2014 to June 2015 at a tertiary care hospital in Karachi. A total of 462 patients, who were referred for magnetic resonance imaging (MRI) brain, presenting with clinical suspicion of an intra-cerebral abscess on the basis of clinical signs and symptoms, were included in this study. MR imaging was performed. All patients subsequently underwent surgery. The histopathological findings of these patients were collected and compared with echo-planar diffusion-weighted MRI findings. A proforma was used to record the findings. The mean age of the patients was 47.39±13.54 years. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of echo-planar diffusion-weighted MRI in the diagnosis of intra-cerebral abscesses was 85.64%, 95.88%, 93.82%, 90.14%, and 91.56%, respectively. Brain abscesses and necrotic tumors are, most of the time, difficult to differentiate on routine conventional imaging, and prompt diagnosis is important, as an untreated brain abscess could be lethal. Diffusion imaging can aid in the diagnosis and further management plan so as to help in improved patient care. Although this sequence has high sensitivity and specificity, it should be used in addition to conventional imaging and not as a replacement of histopathology.
- Open Access
- 1 June 2011
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (11) , 3706-3715
Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
Purpose: Chk1 inhibitors, such as AZD7762, are in clinical development in combination with cytotoxic agents for the treatment of solid tumors, including pancreatic cancers. To maximize the likelihood of their clinical success, it is essential to optimize drug scheduling as well as pharmacodynamic biomarkers in preclinical models. Experimental Design: We tested multiple schedules of administration of gemcitabine and AZD7762 on the survival of pancreatic cancer cells. Potential pharmacodynamic biomarkers including pChk1, pChk2, pHistone H3, and caspase-3 were evaluated in vitro, followed by assessment of promising candidate biomarkers in vivo. We then went on to determine the contributions of PP2A and DNA damage to the mechanism(s) of induction of the identified biomarker, pS345 Chk1. Results: AZD7762 given during and after or after gemcitabine administration produced maximum chemosensitization. In vivo, AZD7762 significantly inhibited the growth of pancreatic tumor xenografts in response to gemcitabine. Of the biomarkers assessed, pS345 Chk1 was most consistently increased in response to gemcitabine and AZD7762 in tumors and normal tissues (hair follicles). pS345 Chk1 induction in response to gemcitabine and AZD7762 occurred in the presence of PP2A inhibition and in association with elevated γH2AX, suggesting that DNA damage is an underlying mechanism. Conclusions: AZD7762 sensitizes pancreatic cancer cells and tumors to gemcitabine in association with induction of pS345 Chk1. Together these data support the clinical investigation of AZD7762 with gemcitabine in pancreatic cancer under a dosing schedule in which gemcitabine is administered concurrent with or before AZD7762 and in conjunction with skin biopsies to measure pS345 Chk1. Clin Cancer Res; 17(11); 3706–15. ©2011 AACR.
- 1 June 2011
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (11) , 3706-3715
Open AccessAssessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
Purpose: Chk1 inhibitors, such as AZD7762, are in clinical development in combination with cytotoxic agents for the treatment of solid tumors, including pancreatic cancers. To maximize the likelihood of their clinical success, it is essential to optimize drug scheduling as well as pharmacodynamic biomarkers in preclinical models. Experimental Design: We tested multiple schedules of administration of gemcitabine and AZD7762 on the survival of pancreatic cancer cells. Potential pharmacodynamic biomarkers including pChk1, pChk2, pHistone H3, and caspase-3 were evaluated in vitro, followed by assessment of promising candidate biomarkers in vivo. We then went on to determine the contributions of PP2A and DNA damage to the mechanism(s) of induction of the identified biomarker, pS345 Chk1. Results: AZD7762 given during and after or after gemcitabine administration produced maximum chemosensitization. In vivo, AZD7762 significantly inhibited the growth of pancreatic tumor xenografts in response to gemcitabine. Of the biomarkers assessed, pS345 Chk1 was most consistently increased in response to gemcitabine and AZD7762 in tumors and normal tissues (hair follicles). pS345 Chk1 induction in response to gemcitabine and AZD7762 occurred in the presence of PP2A inhibition and in association with elevated γH2AX, suggesting that DNA damage is an underlying mechanism. Conclusions: AZD7762 sensitizes pancreatic cancer cells and tumors to gemcitabine in association with induction of pS345 Chk1. Together these data support the clinical investigation of AZD7762 with gemcitabine in pancreatic cancer under a dosing schedule in which gemcitabine is administered concurrent with or before AZD7762 and in conjunction with skin biopsies to measure pS345 Chk1. Clin Cancer Res; 17(11); 3706–15. ©2011 AACR.